Display options
Cite
Pfeiffer S, Halang L, Düssmann H, et al. BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes. Cell Death Discov. 2015;1:15041doi: 10.1038/cddiscovery.2015.41.
Pfeiffer, S., Halang, L., Düssmann, H., Byrne, M. M., & Prehn, J. (2015). BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes. Cell death discovery, 115041. https://doi.org/10.1038/cddiscovery.2015.41
Pfeiffer, S, et al. "BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes." Cell death discovery vol. 1 (2015): 15041. doi: https://doi.org/10.1038/cddiscovery.2015.41
Pfeiffer S, Halang L, Düssmann H, Byrne MM, Prehn J. BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes. Cell Death Discov. 2015 Oct 05;1:15041. doi: 10.1038/cddiscovery.2015.41. eCollection 2015. PMID: 27551471; PMCID: PMC4979461.
Copy Download .nbib Format: NLM
Share it on

Cell Death Discov. 2015 Oct 05;1:15041. doi: 10.1038/cddiscovery.2015.41. eCollection 2015.

BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes.

Cell death discovery

S Pfeiffer, L Halang, H Düssmann, M M Byrne, Jhm Prehn

Affiliations

  1. Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland , 123 St. Stephen's Green, Dublin 2, Ireland.
  2. Department of Endocrinology, Mater Misericordiae University Hospital , 30 Eccles Street, Dublin 7, Ireland.

PMID: 27551471 PMCID: PMC4979461 DOI: 10.1038/cddiscovery.2015.41

Abstract

Heterozygous loss-of-function mutations in the hepatocyte nuclear factor 1α (HNF-1α) gene can lead to diminished amounts of functional HNF-1α, resulting in the onset of a particularly severe form of maturity-onset diabetes of the young (MODY). We have previously shown that induction of a dominant-negative mutant of HNF-1α (DNHNF-1α) results in the activation of the bioenergetic stress sensor AMP-activated protein kinase (AMPK), preceding the onset of apoptosis and the induction of pro-apoptotic Bcl-2 homology domain-3-only protein Bmf (Bcl-2-modifying factor) as a mediator of DNHNF-1α-induced apoptosis. Through the knockout of bmf in a transgenic mouse model with DNHNF-1α suppression of HNF-1α function in pancreatic beta-cells, this study aimed to examine the effect of loss-of-function of this BH3-only protein on the disease pathology and progression, and further elucidate the role of Bmf in mediating DNHNF-1α-induced beta-cell loss. Morphological analysis revealed an attenuation in beta-cell loss in bmf-deficient diabetic male mice and preserved insulin content. Surprisingly, bmf deficiency was found to exacerbate hyperglycemia in both diabetic male and hyperglycemic female mice, and ultimately resulted in a decreased glucose-stimulated insulin response, implicating a role for Bmf in glucose homeostasis regulation independent of an effect on beta-cell loss. Collectively, our data demonstrate that Bmf contributes to the decline in beta-cells in a mouse model of HNF1A-MODY but is also required for the maintenance of glucose homeostasis in vivo.

References

  1. Int J Biochem Cell Biol. 2007;39(3):497-504 - PubMed
  2. Nat Med. 1997 Jun;3(6):614-20 - PubMed
  3. J Cell Biol. 2013 Apr 29;201(3):427-37 - PubMed
  4. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7300-4 - PubMed
  5. PLoS One. 2014 Oct 28;9(10):e110384 - PubMed
  6. Diabetes Care. 1990 Jan;13(1):49-64 - PubMed
  7. J Biol Chem. 2002 Feb 22;277(8):6413-21 - PubMed
  8. Cell Death Differ. 2010 Nov;17 (11):1672-83 - PubMed
  9. Diabetes. 1996 Nov;45(11):1503-10 - PubMed
  10. Diabetes. 2013 Jan;62(1):170-82 - PubMed
  11. Mol Cell Biol. 2005 May;25(9):3620-9 - PubMed
  12. Development. 1991 Oct;113(2):589-99 - PubMed
  13. Cell. 1989 Oct 6;59(1):145-57 - PubMed
  14. Oncogene. 2008 Dec;27 Suppl 1:S41-52 - PubMed
  15. EMBO J. 2000 Aug 15;19(16):4257-64 - PubMed
  16. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1323-32 - PubMed
  17. Cell. 1997 Nov 28;91(5):627-37 - PubMed
  18. Diabetes. 2001 Jun;50(6):1290-301 - PubMed
  19. Apoptosis. 2011 Aug;16(8):822-30 - PubMed
  20. J Biol Chem. 2010 Nov 12;285(46):36199-206 - PubMed
  21. Science. 1997 Feb 21;275(5303):1132-6 - PubMed
  22. Diabetes. 2014 Aug;63(8):2744-50 - PubMed
  23. Science. 2001 Sep 7;293(5536):1829-32 - PubMed
  24. Diabetes. 2013 Jul;62(7):2204-14 - PubMed
  25. Diabetes. 2010 Nov;59(11):2799-808 - PubMed
  26. Nat Genet. 2001 Apr;27(4):375-82 - PubMed
  27. Diabetes. 2003 Jan;52(1):102-10 - PubMed
  28. Diabetes. 2012 Feb;61(2):474-84 - PubMed
  29. EMBO J. 1998 Nov 16;17(22):6701-13 - PubMed
  30. Diabetes. 2002 Dec;51 Suppl 3:S333-42 - PubMed
  31. J Exp Med. 2008 Mar 17;205(3):641-55 - PubMed
  32. Cell Death Dis. 2014 Mar 13;5:e1124 - PubMed
  33. Lancet. 1975 Dec 20;2(7947):1243-4 - PubMed
  34. Exp Cell Res. 1989 Sep;184(1):72-80 - PubMed
  35. Biochim Biophys Acta. 1998 Aug 10;1366(1-2):127-37 - PubMed
  36. Diabetes. 1998 Aug;47(8):1231-5 - PubMed
  37. Endocrinology. 2001 Dec;142(12):5311-20 - PubMed
  38. J Biol Chem. 2011 Jul 29;286(30):26533-40 - PubMed
  39. Mol Cell. 1999 Feb;3(2):159-67 - PubMed
  40. Diabetes. 2010 Mar;59(3):644-52 - PubMed
  41. Cell Death Differ. 2005 Nov;12 Suppl 2:1473-7 - PubMed
  42. Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E340-51 - PubMed
  43. Diabetologia. 1985 Jul;28(7):412-9 - PubMed

Publication Types